The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels

Introduction: Cannabidiol (CBD) has been clinically approved for intractable epilepsies, offering hope that novel anticonvulsants in the phytocannabinoid class might be developed. Looking beyond CBD, we have recently reported that a series of biosynthetic precursor molecules found in cannabis displa...

Descripción completa

Detalles Bibliográficos
Autores principales: Udoh, Michael, Bladen, Chris, Heblinski, Marika, Luo, Jia Lin, Janve, Vaishali S., Anderson, Lyndsey L., McGregor, Iain S., Arnold, Jonathon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664070/
https://www.ncbi.nlm.nih.gov/pubmed/36386164
http://dx.doi.org/10.3389/fphar.2022.1048259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664070/
https://www.ncbi.nlm.nih.gov/pubmed/36386164
http://dx.doi.org/10.3389/fphar.2022.1048259

Ejemplares similares